subject area of
- 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Academic Article
- 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Academic Article
- ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series Academic Article
- ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse Academic Article
- ANCA-associated vasculitis patients treated in Polish intensive care units – retrospective characteristics based on the POLVAS registry Academic Article
- Anti-cytokine targeted therapies for ANCA-associated vasculitis Academic Article
- Association between age at disease onset of anti-neutrophil cytoplasmic antibody–associated vasculitis and clinical presentation and short-term outcomes Academic Article
- CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update Academic Article
- CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitides Academic Article
- CanVasc consensus recommendations for the use of avacopan in antineutrophil cytoplasm antibody-associated vasculitis: 2022 addendum Academic Article
- Circulating Angiopoietin-2 as a Biomarker in ANCA-Associated Vasculitis Academic Article
- Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic review Academic Article
- Efficacy of leflunomide in the treatment of vasculitis Conference Paper
- Hypothyroidism in vasculitis Academic Article
- Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis Academic Article
- Intravenous Cyclophosphamide and Plasmapheresis in Dialysis-Dependent ANCA-Associated Vasculitis Academic Article
- Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide Academic Article
- Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial Academic Article
- Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis Academic Article
- Neutrophil extracellular trap formation in anti-neutrophil cytoplasmic antibody-associated and large-vessel vasculitis Academic Article
- Ocular manifestations of ANCA-associated vasculitis Conference Paper
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis Academic Article
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis Academic Article
- Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis Academic Article
- Plasma Exchange in ANCA-Associated Vasculitis: For Whom (If Any)? Academic Article
- Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline Academic Article
- Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT Academic Article
- Preventing Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis—Reply Academic Article
- Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome Academic Article
- Respiratory involvement in antineutrophil cytoplasmic antibody-associated vasculitides: a retrospective study based on POLVAS registry Academic Article
- Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Joneset al’by Vandergheynstet al Academic Article
- Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis Academic Article
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis Academic Article
- Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial Academic Article
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial Academic Article
- The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis Academic Article
- Treatment and its side effects in ANCA-associated vasculitides – Study based on POLVAS registry data Academic Article
- Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis after Rituximab Therapy Academic Article
- Updates in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis: At a crossroad Academic Article
- Urinary Biomarkers in Relapsing Antineutrophil Cytoplasmic Antibody-associated Vasculitis Academic Article
- Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis Academic Article